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Abstract
Many disease-associated variants affect gene expression levels (expression quantitative trait loci, eQTLs) and expression
profiling using next generation sequencing (NGS) technology is a powerful way to detect these eQTLs. We analyzed 94 total
blood samples from healthy volunteers with DeepSAGE to gain specific insight into how genetic variants affect the
expression of genes and lengths of 39-untranslated regions (39-UTRs). We detected previously unknown cis-eQTL effects for
GWAS hits in disease- and physiology-associated traits. Apart from cis-eQTLs that are typically easily identifiable using
microarrays or RNA-sequencing, DeepSAGE also revealed many cis-eQTLs for antisense and other non-coding transcripts,
often in genomic regions containing retrotransposon-derived elements. We also identified and confirmed SNPs that affect
the usage of alternative polyadenylation sites, thereby potentially influencing the stability of messenger RNAs (mRNA). We
then combined the power of RNA-sequencing with DeepSAGE by performing a meta-analysis of three datasets, leading to
the identification of many more cis-eQTLs. Our results indicate that DeepSAGE data is useful for eQTL mapping of known
and unknown transcripts, and for identifying SNPs that affect alternative polyadenylation. Because of the inherent
differences between DeepSAGE and RNA-sequencing, our complementary, integrative approach leads to greater insight
into the molecular consequences of many disease-associated variants.
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Introduction
Genome-wide association studies (GWAS) have associated
genetic variants, such as single nucleotide polymorphisms (SNPs)
and copy number variants (CNVs), with numerous diseases and
complex traits. However, the mechanisms through which genetic
variants affect disease phenotypes or physical traits often remain
unclear. To gain insight into these mechanisms, we have
combined genotype data with gene expression data by conducting
expression quantitative trait locus (eQTL) mapping. Previously,
the level of gene expression was primarily assessed using
oligonucleotide microarrays, which was a powerful method to
profile the transcriptome [1–6]. But recently, high-throughput
next generation sequencing (NGS) has become available, which
allows quantification of expression levels by counting mRNA
fragments (RNA-seq) or sequence tags (including serial analysis of
gene expression (SAGE), cap analysis of gene expression (CAGE),
and massively parallel signature sequencing (MPSS)) [7].
To date, two NGS eQTL studies have been published [8,9],
both of which used RNA-seq. Although RNA-seq is a versatile
technique, the coverage in the ultimate 39-end is usually lower due
to the fragmentation and random hexamer priming steps involved
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in the sample preparation [10] (Figure 1B). DeepSAGE technol-
ogy [11,12], however, concentrates on capturing information on
the 39 end of transcripts. In DeepSAGE, enzymatic cDNA
digestions generate one specific tag of 17 nucleotides at the most
39-CATG sequence of each transcript (Figure 1A). The majority of
these 21-mer tags (‘CATG’ + 17 nucleotides) can be uniquely
mapped to the genome to identify the genes expressed.
There are several features of NGS-based expression quantifica-
tion methods that are especially important for eQTL mapping.
While oligonucleotide arrays target a predefined set of transcripts
or exons, both RNA-seq and DeepSAGE are capable of detecting
novel and unannotated transcripts. If such a novel gene later turns
out to be cis-regulated by trait- or disease-associated SNPs, it can
represent an interesting causal candidate gene for the trait or
disease under investigation. RNA-seq is extremely versatile, as it
can quantify the expression of alternative transcripts, which makes
it possible to detect SNPs regulating the choice between alternative
transcripts. DeepSAGE, however, is generally not suited to
detecting alternative splicing because of the 39 bias of the tag
locations [13]. Because only sequence data is generated for these
short tags, the read depth per tag is generally much greater than
with RNA-seq, permitting accurate quantification of these tags
[11,14]. Thus, this 39 emphasis makes DeepSAGE suitable for
transcript variants that differ in 39-UTRs and also for detecting
alternative polyadenylation events, a widespread phenomenon
that generates variation in 39-UTR length [15,16]. Shortening or
lengthening of the 39-UTR may result in the loss or gain of
regulatory elements, such as miRNA binding sites or binding sites
for proteins that can stabilize or destabilize the transcript [17,18].
Several SNPs that influence the choice for alternative polyade-
nylation sites have been detected by RNA-seq on a small number
of individuals [19]. Here, we analyzed this phenomenon in more
depth by performing cis-eQTL mapping on DeepSAGE data from
total blood samples of 94 individuals.
Results
DeepSAGE dataset
For cis-eQTL mapping, we used DeepSAGE sequencing of
21 bp tags (1667 million tags) from total blood samples from 94
healthy, unrelated individuals from the Netherlands Twin Register
(NTR) and the Netherlands Study of Depression and Anxiety
(NESDA) [20]. Sequence reads were mapped to the reference
genome hg19 using Bowtie [21] and assigned to transcripts. We
mapped 8565% of tags to the genome and found that 7769% of
these mapped to exonic regions. Although 66618% of these reads
mapped to hemoglobin-alpha or –beta (HBA1, HBA2, HBB) genes,
we were left with sufficient sequencing depth to detect a total of
9,562 genes at a threshold of at least two tags per million.
Cis-eQTL mapping
Once reads had been mapped, we quantified the expression
levels of sequenced tags and performed cis-eQTL mapping,
evaluating only those combinations of SNPs and tags that were
located within a genomic distance of 250 kb, while using a
Spearman rank correlation test (tag-level false discovery rate
(FDR) controlled at 0.05). We identified 540 unique cis-regulated
tags.
To subsequently increase the statistical power of eQTL
detection, we used principal component analysis (PCA) to correct
for technical and known and unknown biological confounders.
The first principal components (PC) generally capture a high
percentage of the expression variation, and these PCs mostly
reflect technical, physiological and environmental variability.
Removing this variation allows for the detection of more eQTLs
[6,22,23]. In our data the first principal component significantly
correlated with sample GC content, and principal components 7
and 11 correlated with various blood cell count parameters (for
details see Text S1, Figures S1 and S2). When using the PC
corrected data, we observed an almost two-fold increase in the
number of significant cis-eQTLs (1,011 unique cis-regulated tags,
corresponding to 896 unique cis-regulated genes at tag-level
FDR,0.05). The list of detected eQTLs is given in Table S1.
Comparison with microarray results
We then compared the DeepSAGE cis-eQTLs with cis-eQTLs
that we had identified using the Affymetrix HG-U219 expression
microarrays on the same 94 samples. In that analysis we detected
cis-eQTLs for only 274 genes (FDR,0.05), only a third of what we
identified using DeepSAGE.
We observed that this substantial difference could mostly be
explained by the fact that the cis-eQTLs detected using Affymetrix
microarrays nearly always reflected genes that are highly expressed
in blood, whereas for DeepSAGE the detected cis-eQTL genes
had expression levels that could be much lower (Figure 2).
Although we only concentrated on tags that were expressed, there
was no clear relationship between the mean tag level expression
and the probability of showing a significant cis-eQTL. As such,
DeepSAGE is much more capable of identifying cis-eQTLs for
genes showing low expression than conventional microarrays.
It was therefore not a surprise that only 39% of the identified
DeepSAGE cis-eQTLs could also be significantly detected in the
microarray-based dataset (with identical allelic direction) (Figure
S3). Indeed, the cis-eQTLs that were not replicated in the
microarray-based dataset generally had a much lower expression
than the replicating cis-eQTLs (Wilcoxon Mann Whitney
P,261023).
And vice versa, we could significantly replicate 75% of the
detected Affymetrix cis-eQTLs with the same allelic direction in
the DeepSAGE data (Figure S3), indicating that DeepSAGE
shows overlapping results with array-based data. At the same time,
this provides insight into the regulation of gene expression by
SNPs at many more loci.
We estimated the reduction that could be made in the sample
size of the sequencing-based dataset to get the same number of cis-
regulated genes as in microarray-based data. We observed that the
DeepSAGE sample size could be reduced by almost half (to 55
samples) to get the same number of significant cis-regulated genes
as identified in the microarray analysis of the 94 samples. As such,
Author Summary
Many genetic variants that are associated with diseases
also affect gene expression levels. We used a next
generation sequencing approach targeting 39 transcript
ends (DeepSAGE) to gain specific insight into how genetic
variants affect the expression of genes and the usage and
length of 39-untranslated regions. We detected many
associations for antisense and other non-coding tran-
scripts, often in genomic regions containing retrotransposon-
derived elements. Some of these variants are also
associated with disease. We also identified and confirmed
variants that affect the usage of alternative polyadenyl-
ation sites, thereby potentially influencing the stability of
mRNAs. We conclude that DeepSAGE is useful for
detecting eQTL effects on both known and unknown
transcripts, and for identifying variants that affect alter-
native polyadenylation.
DeepSAGE eQTL Mapping
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these results clearly indicate that DeepSAGE has higher statistical
power than microarrays.
Cis-eQTL effects on non-coding genes
While most microarray platforms interrogate mainly the
protein-coding part of the transcriptome, NGS-based expression
profiling will detect the majority of all expressed transcripts.
Indeed, we detected eQTLs for known, but non-protein coding,
genes: 8 antisense genes and 31 lincRNAs (Figure 3).
We also expected to find a number of cis-eQTL effects on
previously unknown transcripts. Of the 1,011 tags with a
significant cis-eQTL effect, 230 did not map to known transcripts.
Many of these tags map to retrotransposon-derived elements in the
genome, which are known to be a source of novel exons [24]: 73
DeepSAGE tags with significant cis-eQTLs that did not map to
annotated genes mapped to 72 unique LINE, SINE and LTR
elements in the genome (Table 1).
New regulatory roles for disease- and trait-associated
SNPs
We checked how many of our cis-acting SNPs were associated
with complex traits or complex diseases (‘trait-associated SNPs’), as
published in the Catalog of Published Genome-Wide Association
Studies. 104 of the 6,446 unique trait-associated SNPs were
significant cis-eQTLs in our data (Table S2).
We were interested to determine whether the DeepSAGE data
had revealed cis-eQTL effects for trait-associated SNPs that had
been missed when using conventional arrays on much larger
cohorts. We therefore compared our results to a re-analysis of a
large-scale, array-based cis-eQTL mapping that we had conducted
in whole peripheral blood samples when using a much larger
sample size of 1,469 (using Illumina oligonucleotide arrays [6]).
We identified 13 trait-associated SNPs that did show a
significant cis-eQTL effect in DeepSAGE eQTL mapping, but
which did not show a cis-eQTL effect in the large, array-based,
blood dataset (Table 2). This indicates that many trait-associated
SNPs have regulatory effects that will, so far, likely have been
missed using microarrays. While some of the tags map in the exons
of annotated transcripts, we also found three cis-regulated tags in
introns (sense direction), two tags antisense to the known
transcripts, and two tags outside the annotated transcripts. These
results indicate that several trait-associated SNPs affect the
expression of previously unknown transcripts, adding functional
relevance to SNPs and transcripts that are so far without
annotation.
Some newly discovered eQTLs provide novel insights into
genome-wide association hits for diseases or physiological traits,
e.g. SNP rs216345, which has been associated with bipolar
disorder. While it is located just downstream of PRSS3, we now
saw that it also affects the expression of UBE2R2. There are many
links between the ubiquitin system and bipolar disorder reported
in the literature (e.g. [25,26]), making UBE2R2 a more plausible
candidate gene for bipolar disorder than PRSS3.
Genes with multiple SAGE tags and opposite allelic
direction
In DeepSAGE, 21-bp-long cDNA fragments begin at the
‘CATG’ closest to the polyadenylation site (Figure 1). These
Figure 1. Comparison of typical DeepSAGE and RNA-seq data generation steps. A) DeepSAGE data preparation consists of the following
basic steps: after RNA extraction the polyadenylated mRNA fraction is captured with oligo-dT beads. While RNA is still bound to the beads, double-
stranded cDNA synthesis is performed. Next, cDNA is digested by NlaIII restriction enzyme (an anchoring enzyme), which cuts the DNA at CATG
recognition sequences, leaving only the fragment with the most distal (39) CATG site associated with the beads. Subsequently, a GEX adapter is
attached to the 59 end. This adapter contains a recognition sequence for the MmeI restriction enzyme that cuts the sequence 17 bp downstream of
CATG site. After ligation of a second GEX adapter, fragments containing 21 bp tags (17 unknown nucleotides + CATG) are ready for sequencing. B) A
typical protocol for RNA-seq data preparation has the following steps: after RNA extraction the polyadenylated mRNA fraction is captured with oligo-
dT beads. Captured RNA is fragmented and for each fragment cDNA synthesis is performed using random hexamer primers. Sequencing adapters are
then ligated to each fragment. This is followed by size selection of the DNA fragments and PCR amplification. Then one end of the fragment is
sequenced (single-end sequencing) or both ends (paired-end sequencing).
doi:10.1371/journal.pgen.1003594.g001
Figure 2. Fraction of cis-regulated genes in bins by mean gene expression levels for DeepSAGE and Affymetrix data. For each dataset,
all genes were sorted by their mean gene expression levels, and divided into ten equal bins. The X-axis reflects these bins, which are sorted by
increasing mean gene expression levels. The Y-axis reflects the fraction of cis-regulated genes that fall into each bin.
doi:10.1371/journal.pgen.1003594.g002
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individual ‘tags’ represent transcripts sharing the same polyade-
nylation site. If a SNP increases the abundance of one tag of a gene
and decreases the abundance of another tag of the same gene, this
indicates that the SNP is acting like a switch between transcripts
with different 39-UTRs or between alternative polyadenylation
sites [19] (Figure 4).
Twelve genes with highly significant cis-eQTLs (p-value,1027)
contained tags that were regulated in opposite directions (Table 3).
Most of the tags regulated in opposite direction could be explained
by switches in alternative polyadenylation sites, as the tags were
observed in the same last exon. The effect on alternative
polyadenylation in IRF5 has been found before [19,27] and was
also validated in our cohort by RT-qPCR with primers in the
proximal and distal parts of the 39-UTR (Figure 5). As a further
confirmation of the observed switches in using polyadenylation
sites, we tested genotype-dependent alternative polyadenylation in
two other RNA-seq datasets [8,9]. In these datasets, we confirmed
the effect of two cis-regulating SNPs on THEM4 and F11R.
However, we could not confirm the effect of other SNPs on targets
validated experimentally, including IRF5. This shows the limita-
tion of RNA-seq data in detecting alternative polyadenylation
events, likely due to limited and unequal coverage of the 39-UTR.
For only two genes, OAS1 (also reported earlier [28]) and RP11-
493L12.2, the observed opposite allelic effect originated from
transcripts with different last exons, likely due to alternative
splicing.
As we has identified several SNPs that affect alternative
polyadenylation, we subsequently used a more permissive strategy,
which required that, for a given SNP, only one eQTL tag should
pass the FDR,0.05 significance threshold while the other tag
could be less significant. However, for such SNP-tag pairs, we then
tested whether the allelic directions were opposite and if the
difference between correlation coefficients was significant. With a
differential correlation significance p-value threshold of 1027, we
detected 41 unique genes showing regulation in opposite directions
(Table S3). Of these, 23 (56%) showed opposite regulation of two
tags in the same annotated 39-UTR and a further 7 genes (17%)
showed opposite regulation of tags in the same exons, both
indicative of a switch in polyadenylation sites. Of these we picked
HPS1, and validated a genotype-determined switch in preferred
polyadenylation site usage by RT-qPCR analysis (Figure 5),
indicating that the more permissive list also holds genuine changes
in polyadenylation sites. The remaining 11 genes showed
significant genotype-determined switches in expression of alterna-
tive transcripts not sharing the final exon. Thus, switches between
shorter and longer 39-UTRs occur more frequently than switches
between transcripts with different 39-UTRs.
To check whether such results appeared by chance, we took an
equal number of top hits from a permuted eQTL run (shuffling the
phenotype labels of the expression data, thus breaking the
Figure 3. Mapping regions of cis-regulated tags. The gene biotypes and exon/intron locations of unique cis-regulated tags, according to
Ensembl v.69 annotation, are shown. The numbers indicate the number of tags mapping in the genes of the corresponding type.
doi:10.1371/journal.pgen.1003594.g003
Table 1. Number of cis-regulated tags mapping to different
genomic regions in tag-wise DeepSAGE eQTL mapping.
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relationship between genotype and expression, but retaining
linkage disequilibrium (LD) structure and structure in the
expression data) and performed the same analysis as above
(assessing an equal number of top eQTLs from the permuted
analysis as we had investigated in the real analysis). Using the
differential correlation significance threshold of 1027 and
conducting this permutation analysis ten times, we did not find
any SNP that affected two tags in the same gene in a significantly
different way, indicating this method is robust.
Since the eQTL SNPs are usually in strong LD with multiple
SNPs, it is difficult to conclude whether a SNP is causal or which
SNP is the likely causal variant. To identify the likely causal
variant, we assessed whether any of these SNPs caused changes in
polyadenylation site usage. A direct effect on alternative
polyadenylation can be explained by a change in the polyade-
nylation site (corresponding to the cleavage site) or in the
polyadenylation signal (a six-nucleotide motif located between
10–30 bases upstream of the cleavage site). We searched for likely
causative SNPs in linkage disequilibrium with the polyA-QTL
SNP (R2$0.8). We did not find any strong evidence for SNPs
influencing the cleavage site and focused on cis-regulating SNPs
located within polyadenylation signals. Considering the length
and the motif of canonical and non-canonical polyadenylation
signals [15], we performed a motif analysis in the sequence
surrounding each cis-regulating SNP. We identified five SNPs
that likely affect polyadenylation because there was a change in
the polyadenylation signal (Table 4). As previously shown,
rs10954213 causes the formation of a stronger polyadenylation
signal in IRF5. Similar changes from non-canonical to stronger,
canonical polyadenylation signals were observed for rs1062827 in
F11R and rs6598 in GIMAP5. Moreover, rs12934747 creates a
new canonical AATAAA polyadenylation signal in LPCAT2. The
presence of this alternative polyadenylation signal at the
beginning of the 39-UTR leads to a decrease in transcripts
containing the full length 39-UTR, as observed by DeepSAGE
(Figure 6). An opposite effect is observed for rs7063 in the
ultimate 39-end of the ERAP1 gene, where the SNP causes the
disruption of the strong canonical motif, and results in the use of
a more proximal polyadenylation signal. Unfortunately we were
not able to identify likely causative SNPs for each of these
eQTLs. This could have several reasons: we imposed strict
thresholds (R2$0.8) on the LD between the detected cis-eQTLs
and the putative causative SNPs; by imputing to the 1000
genomes dataset we may have missed causative SNPs unique to
the Dutch population; and the list of experimentally validated
polyadenylation sites is not exhaustive, because their detection
depends on the expression level and cell type analyzed.
Seven of the SNPs affecting polyadenylation are reported in the
GWAS catalog as associated with diseases (Table S3), including
rs2188962 and rs12521868, which are associated with Crohn’s
disease. We found that these SNPs were associated with a switch in
the polyadenlyation site of IRF1. This may reinforce previous
evidence that IRF1 is the gene in the IBD5 locus responsible for its
association with Crohn’s disease [29]. IRF1 is a family member of
the IRF5 gene. Thus, in the family of interferon regulatory factors,
we found two members with genetic regulation of alternative
polyadenylation sites, likely explaining susceptibility for Crohn’s
disease and systemic lupus erythematosus, respectively.
Another example is rs3194051, located in the IL7R gene. This
SNP was not found in the analysis described above since it affects
the expression of a tag on the same strand, downstream of IL7R in
a LINE element (Table 2). However, this tag may represent an
alternative 39-UTR for IL7R. The SNP is associated with
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Figure 4. The number of cis-regulated tags per gene. The percentages of cis-regulated tags mapping into the same gene are indicated (781
genes overall). For nearly half of the genes (48%) only one tag shows an eQTL effect. If multiple tags map within the same gene, only one eQTL tag
should pass the FDR,0.05 significance threshold while the other tag could be less significant. For these eQTLs the allelic direction is shown: same
allelic direction (multiple tags within the same gene are cis-regulated by a SNP in the same direction), significantly opposite allelic direction (multiple
tags within the same gene are cis-regulated by a SNP but with opposite directions and the difference between the correlation coefficients is
significant), or opposite allelic direction but not significant (if the difference between correlation coefficients is not significant).
doi:10.1371/journal.pgen.1003594.g004
Figure 5. The choice of proximal/distal polyadenylation site in genes IRF5 and HPS1 depends on the genotypes of rs10488630 and
rs11189600, respectively. The ratio between the abundance of transcripts with proximal and distal 39-UTR RT-qPCR products in IRF5 (left) and
HPS1 (right) depends on the genotypes of cis-regulating SNPs rs10488630 and rs11189600, respectively. N denotes the number of individuals
included in the analysis. These results indicate allele-specific preference for use of a proximal and distal polyadenlyation site.
doi:10.1371/journal.pgen.1003594.g005
DeepSAGE eQTL Mapping
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the inflammatory response pathway demonstrating alternative
polyadenylation.
Meta-analysis with RNA-seq data
In order to increase the statistical power to detect
associations of SNPs with gene expression, we performed a
first-of-its-kind eQTL mapping meta-analysis, combining
DeepSAGE data with two published RNA-seq datasets. We
used paired-end sequencing of mRNA derived from lympho-
blastoid cell lines from HapMap individuals of European
origin [8] and 35 and 46 bp single-end sequencing of mRNA
derived from lymphoblastoid cell lines from HapMap individ-
uals of Yoruba origin [9]. Sequence reads were mapped to the
reference genome hg19 using Tophat [30] and assigned to
transcripts. A consistently high percentage of reads (86–87% of
aligned reads) mapped to exonic regions (Table 5).
We first performed eQTL mapping separately in all three datasets
(Table 6), summarizing expression on the transcript level to permit
comparisons between the datasets. The numbers of cis-regulated
genes detected in transcript-wise analysis was lower than in tag-wise
analysis, possibly because wemissed resolution on alternative splicing-
and alternative polyadenylation events. Again, PC correction greatly
improved the number of cis-eQTLs detected (Table 6).
We applied PC correction to the individual datasets. As for
the DeepSAGE analysis, the first PC correlated strongly with
the mean GC-percentage in the two RNA-seq datasets (Figure
S1). We then assessed the robustness of the identified cis-
eQTLs: we checked whether those in one dataset could be
significantly replicated in the other two datasets. We observed
that in each of the RNA-seq datasets approximately one-third
of cis-eQTLs could be replicated in the other dataset (Table
S4). The overlap between RNA-seq and DeepSAGE was
smaller, reflecting differences in the two technologies, in cell
types and in populations. In each comparison, we observed a
very high concordance in the allelic direction of cis-eQTLs that
could be replicated in another dataset.
We also looked at the replication of RNA-seq eQTLs in
corresponding micro-array-based datasets. 80–88% of such
eQTLs could be replicated in microarray data (Table S5).
As we could cross-replicate many cis-eQTLs, we decided to
conduct a meta-analysis to increase the statistical power. We
calculated joint p-values using a weighted Z-score method. The
number of cis-regulated genes then increased to 1,207 unique
genes (Table 6) (a list of detected eQTLs is given in Table S6),
indicating that a meta-analysis of different types of sequencing-
based eQTL datasets reveals many more cis-regulated genes than
the individual analyses.
For our meta-analysis results we determined the number of
disease- and trait-associated SNPs using the Catalog of Published
Genome-Wide Association Studies in the same way as for the
DeepSAGE dataset. 107 of the 6,446 unique trait-associated SNPs
showed a significant cis-eQTL effect in the meta-analysis. The









Score HGNC Name Annotation
rs12568757 G/A G 1 150782318 4.404 ARNT Alternative polyadenylation
1 150782604 24.314
rs12566232 A/C C 1 151846229 26.859 THEM4 Alternative polyadenylation
1 151846628 4.292
rs1062826 G/C C 1 160965239 24.46 F11R Alternative polyadenylation
1 160966976 8.012
rs13160562 G/A A 5 96110323 27.883 ERAP1 Alternative polyadenylation
5 96111908 5.555
rs3185733 A/C A 5 112320282 4.027 DCP2 Alternative polyadenylation
5 112356357 24.46
rs6948928 T/C T 7 128589824 8.451 IRF5 Alternative polyadenylation
7 128589265 27.31
rs2111903 G/C C 12 47603121 5.143 RP11-493L12.2 Different exon
12 47599911 24.676
rs841718 A/G G 12 57489368 5.506 STAT6 Alternative polyadenylation
12 57489809 27.002
rs2285934 G/T T 12 113357275 4.931 OAS1 Different exon
12 113355465 25.191
rs168822 C/T T 16 55616984 7.37 LPCAT2 Alternative polyadenylation
16 55620233 24.664
rs922446 T/C T 16 56395733 24.966 AMFR Alternative polyadenylation
16 56396100 4.392
rs1674159 C/T T 19 5915589 27.103 CAPS Alternative polyadenylation
19 5916143 6.126
*Only significant eQTLs with FDR,0.05 for both cis-regulated tags were used.
doi:10.1371/journal.pgen.1003594.t003
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overlap with 104 trait-associated SNPs detected in tag-wise
DeepSAGE eQTL mapping was 37, indicating that the Deep-
SAGE transcript end quantification revealed other trait-associated
cis-eQTLs than a meta-analysis on the level of whole transcripts.
21 of the 107 SNPs showed a significant cis-eQTL effect in the
sequencing-based meta-analysis, but did not show a cis-eQTL
effect in the large array-based blood dataset (Table 7).
Discussion
We have described the results from cis-eQTL mapping on
DeepSAGE sequencing, a technique that is different from RNA-seq
since it mainly targets the 39-end of transcripts. We identified 1,011
unique cis-regulated tags (significant at tag-level FDR,0.05).
We performed eQTL mapping on the microarray expression
data of the same samples and the number of detected cis-eQTLs was
much smaller than in the DeepSAGE data, indicating the higher
power of DeepSAGE in eQTL mapping. Moreover, for 220 of the
cis-eQTLs SNPs detected by DeepSAGE we did not detect a
significant cis-eQTL in a much larger microarray-based study in
1,469 whole peripheral blood samples [6]. 13 of these SNPs were
reported as disease- or trait-associated in the GWAS catalog.
We observed that the number of cis-eQTLs detected in
microarray data was higher in highly expressed genes, whereas
for DeepSAGE the detected cis-eQTL genes had expression levels
that could be much lower (Figure 2). This means that DeepSAGE
is much better at identifying cis-eQTLs for genes showing low
expression than conventional microarrays. This is because gene
Figure 6. rs12934747*T creates a poly(A) signal in LPCAT2 and leads to alternative polyadenylation site usage. The y-axis represents
the number of counts for the deepSAGE tags. Two samples with different genotypes for SNP rs12934747, CC (reference allele) and TT (alternative
allele), are shown as different traces. Below the coverage tracks, the position of rs12934747 is shown, together with the position of all reported
polyadenylation sites from polyA_DB. An enlargement of the region containing the SNP is shown below. rs12934747 is located at the beginning of
the 39-untranslated region (39-UTR) of LPCAT2, 27 nucleotides upstream a reported and experimentally validated polyadenylation site. This SNP
changes the sequence, creating a polyadenylation signal that leads to the usage of the reported polyadenylation site. The square block indicates the
sequence of the polyadenylation signal created by rs12934747. The creation of this signal shortens the 39-UTR, as indicated by the higher abundance
of the proximal DeepSAGE just upstream of the polyadenylation signal, and the nearly absent distal DeepSAGE, in the sample with the TT genotype
(both tags indicated by arrows). Tag 2 was filtered out because it was expressed in less than 90% of individuals. There is an additional tag 3 in-
between the proximal and distal tags, which is not cis-regulated.
doi:10.1371/journal.pgen.1003594.g006
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expression quantification using microarrays is more difficult as
there is always a background signal present that needs to be
accounted for. This is not the case for next-generation sequencing:
although stochastic variation plays a major role in determining
what RNA molecules will eventually be sequenced (especially for
transcripts of low abundance), detection of such an RNA molecule
is direct proof that it is being expressed.
Clearly, DeepSAGE can capture events that are likely to be
missed by RNA-seq and conventional microarrays. It is not
surprising, due to the different emphasis of DeepSAGE, that we
could only replicate 39% of the DeepSAGE cis-eQTLs in the
microarray data with a consistent allelic direction (Figure S3). The
limited overlap between DeepSAGE- and microarray-based
eQTL studies may be partly explained by the fixed thresholds
applied, the interrogation of different transcript variants, and by
the smaller dynamic range of microarrays. In addition, we found
that more highly expressed genes were more often replicated than
lower expressed ones.
Moreover, DeepSAGE allows for the detection of non-coding
and novel transcripts not present on the microarrays. We showed
that genetic variation affects the expression of a substantial
number of lincRNAs and antisense genes, some of which have
been linked to clinical traits. This suggests that clinical traits may
be modified by expression of antisense transcripts or alternative 39-
UTR selection, which are not separately quantified in the
microarray-based studies or in most RNA-seq, where standard
protocols are still not strand-specific.
We also noticed a relatively high proportion of eQTLs with
DeepSAGE tags mapping in SINE, LINE and LTR elements.
These transposable elements contribute to the evolution and inter-
individual variation of the human genome and to the diversifica-
tion of the transcriptome, the latter facilitated by their inherent
potential to be transcribed and the presence of cryptic splice
acceptor and donor sites [24,31,32]. Some of the DeepSAGE tags
we identified may be located in entirely new transcripts, but the
majority is likely to represent alternative exons or 39-UTRs of
known transcripts, in accordance with the observed preferential
location in introns or near genes.
Associations with transcripts and transcript variants not yet
annotated may help to discover a function for these transcripts, as
they are likely to play a role in the physiological and clinical traits
associated with the SNP. Moreover, this will complement our
knowledge of the pathways associated with these physiological and
clinical traits.
In our study, we have demonstrated that genotype-dependent
switches in the preference of alternative polyadenylation sites are
common. One of these events has been well characterized: SNP
rs10954213 creates an alternative polyadenylation site in IRF5,
shortens the 39-UTR, stabilizes the mRNA, and increases IRF5
expression, explaining its genetic association with systemic lupus
erythematosus [19,27]. We have now discovered more examples
where SNPs create or disrupt polyadenylation motifs. Amongst
others, we identified a new, similar, genotype-dependent switch in
preferred polyadenylation site for family member IRF1, with a
probable link to Crohn’s disease. Alternative polyadenylation
associated with shortening of 39-UTRs is a prominent event in
the activation of immune cells [18]. Thus, genetically determined
use of a proximal polyadenylation sites may predispose to
inflammatory disorders such as Crohn’s disease. The opposite
correlations that we observed for most genes were slightly less
pronounced than for IRF5. This indicates that mechanisms other
than the creation or disruption of canonical polyadenylation motifs
may also play a role. For example, SNPs in miRNA or protein-
binding sites may specifically affect the stability of the transcript
variant with the long 39-UTR.
We subsequently conducted a cis-eQTL meta-analysis on the
heterogeneous types of data using methods extended from those we
developed for microarray-based eQTL meta-analysis [6]. We
identified 1,207 unique cis-regulated genes. This number is
substantially higher than in each of the datasets separately and
indicates that different protocols for digital gene expression
generally deliver consistent results. Nevertheless, the overlap at a
fixed FDR of 0.05 is rather small, in particular between DeepSAGE
and RNA-seq data. While this is partly attributable to using a strong
threshold, there are other important reasons: firstly, the RNA-seq
and DeepSAGE technologies frequently interrogate different
transcript variants. Secondly, the RNA-seq studies were done on
lymphoblastoid cell lines (LCLs) while the DeepSAGE study was on
total blood, and some cis-eQTLs may be tissue-specific [33,34].
Finally, the DeepSAGE technology is strand-specific but the RNA-
seq technologies evaluated here are not: where DeepSAGE will
evaluate the expression of sense and antisense transcripts separately,
RNA-seq will sum them. These reasons could explain why the
percentage of RNA-seq-derived eQTLs that can be replicated by
DeepSAGE is higher than the percentage of DeepSAGE-derived
eQTLs that can be replicated by RNA-seq.
We conclude that DeepSAGE technology is useful to determine
cis-eQTLs, as it is able to quantify the expression of novel transcripts,
and to detect alternative polyadenylation effects and alternative 39-
UTR selection. It is complementary to other sequencing-based
approaches, as they each reveal slightly different regulatory effects of
genetic variants. Different sequencing-based eQTL analyses gener-
ally deliver consistent results, allowing for meta-analyses across
different technologies. Future eQTL mapping studies based on
Table 4. SNPs that likely affect polyadenylation due to a change in the polyadenylation signal.
Cis-regulating









Formation/activation of polyA signal
rs6948928 rs10954213 0.76* G/A IRF5 AATGAA AATAAA 15 Shortening
rs168822 rs12934747 0.87 C/T LPCAT2 AACAAA AATAAA 27 Shortening
rs1062826 rs1062827 0.99 G/A F11R AGTAAA AATAAA 21 Shortening
rs759011 rs6598 1 G/A GIMAP5 AATAGA AATAAA 13 Shortening
Disruption of polyA signal
rs13160562 rs7063 1 T/A ERAP1 AATAAA AAAAAA 23 Shortening
*This SNP was reported in [27] and is validated by our data.
doi:10.1371/journal.pgen.1003594.t004
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DeepSAGE and other next generation sequencing strategies, using
larger cohorts and different techniques, will likely reveal a more
comprehensive picture of how far genetic variation affects the
expression of protein-coding genes and non-coding RNAs.
Materials and Methods
Ethics statement
The medical ethical committee of the VUMC, Amsterdam, the
Netherlands, approved the collection and analysis of material
blood, DNA and RNA from the 94 participants from the
Netherlands Twin Registry (NTR) and the Netherlands Study of
Depression and Anxiety (NESDA).
NTR-NESDA dataset
We analyzed 21 bp DeepSAGE data from total blood RNA of
94 unrelated individuals who participated in NTR or NESDA.
RNA was isolated using PaxGene tubes [20,35,36]. DeepSAGE
sample preparation protocols, and alignment approaches were
described in [37]. One sample was run on one lane of the Illumina
GAII instrument. Data are available in ArrayExpress under
accession number E-MTAB-1181.
The NTR-NESDA data was imputed using Beagle v3.1.0, with
HapMap2 release 24 as a reference.
Tag mapping and expression estimation
Tags from DeepSAGE sequencing were aligned to the NCBI
build 37 reference genome using Bowtie v. 0.12.7 allowing for a
maximum of 1 mismatch and a maximum of 2 possible alignments
(-n 1 -k 1 -m 2 –best –strata options).
The expression values were both quantified on an individual tag
and transcript level. For the tag-wise analysis, the total number of
occurrences of each unique tag in each sample was counted. We
only included tags that were present in .90% of samples. Tags
with SNPs in the CATG recognition sequence (according to
dbSNPv135) and the transcripts containing those tags were
removed before eQTL analysis, since these SNPs can affect the
position of the SAGE tag in the transcript. For the transcript-wise
analysis, the tag counts for tags overlapping the exons of a
transcript by at least half of the tag length were summed.
Coordinates of LINE, SINE, LTR elements were derived from
UCSC’s RepeatMasker track (update: 2009-04-24).
GC content bias estimation
To calculate the GC content per individual for DeepSAGE
data, GC frequencies for all mapped tags were summed after
excluding the twenty most abundant tags, since their high
abundance would give biased estimates.
Cis-eQTL mapping and correction for confounding
effects through principal component analysis
Before eQTL mapping, transcript and tag expression values
were quantile normalized. To perform cis-eQTL mapping,
association of SNPs with the expression levels of tags or transcripts
within a distance of 250 kb (as this is the average size of linkage
regions) of the midpoint of the transcript or tag were tested with a
non-parametric Spearman’s rank correlation. Multiple testing
correction was performed, controlling the false discovery rate
(FDR) at 0.05. To determine the FDR, we created a null
distribution by repeating the cis-eQTL analysis after permuting
the sample labels 10 times [38].
We argue that gene expression levels from NGS-based datasets
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and environmental effects. As such, compensating for these non-
genetic effects would increase the power to detect cis-eQTL effects.
To mitigate the effects of non-genetic sources of variability, we first
log2 transformed the data and centered and scaled each tag, and
subsequently applied PCA on the sample correlation matrix. We
then used the first PCs as covariates, and re-did the non-
parametric cis-eQTL mapping on the residual expression data
(using the procedure described by [6]).
Validation of genotype-dependent alternative
polyadenylation in RNA-seq datasets
The genomic coordinates of the 39-UTR, obtained from Refseq
Genes, were split into two separate regions (distal and proximal 39-
UTRs) according to the position of the DeepSAGE tags with opposite
directions, the position of LongSAGE tags from CGAP, and the
position of reported and predicted polyadenylation sites from
polyA_DB database. To calculate the coverage in proximal and distal
regions in RNA-seq datasets, we created a coverage histogram from
each .bam alignment file using coverageBed tool from BEDTools
package (version 2.17.0) [39]. Subsequently, a custom Python script
was used to convert the histogram in number of nucleotides mapped
per region, normalized by the length of the region. The ratio between
the number of counts in the proximal region and the distal region was
then calculated.
qPCR validation of alternative polyadenylation
Expression of short and long variants of HPS1 and IRF5 was
quantified by qRT-PCR, which was performed on a subset of
RNA samples used for the DeepSAGE sequencing. cDNA was
synthesized from 400 ng of total RNA using BioScript MMLV
Table 6. Number of detected cis-eQTLs in transcript-wise analysis of three harmonized RNA NGS datasets.





Montgomery et al. (paired-end RNA-seq) 94 145
Pickrell et al. (single-end RNA-seq) 199 438
NTR-NESDA transcript-wise (DeepSAGE) 292 579
Meta-analysis 651 1,207
doi:10.1371/journal.pgen.1003594.t006
Table 7. Trait-associated SNPs detected in the sequencing-based transcript-wise meta-analysis, but not detected in array-based




(midpoint) Cis-regulated gene Associated trait
rs1052501 3 41963564 ULK4 Multiple myeloma
rs347685 3 141782879 TFDP2 Chronic kidney disease
rs4580814 5 1081324 SLC12A7 Hematological and biochemical traits
rs4947339 6 28911984 C6orf100 Platelet aggregation
rs2517532 6 31024818 HCG22 Hypothyroidism
rs2844665 6 31024818 HCG22 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
rs6457327 6 31024818 HCG22 Follicular lymphoma
rs3130501 6 31324124 HLA-B Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
rs2858870 6 32434437 HLA-DRB9 Nodular sclerosis Hodgkin lymphoma
rs3129889 6 32434437 HLA-DRB9 Multiple sclerosis
rs3135388 6 32434437 HLA-DRB9 Multiple sclerosis
rs477515 6 32434437 HLA-DRB9 Inflammatory bowel disease
rs9271100 6 32524134 HLA-DRB6 Systemic lupus erythematosus
rs9273349 6 32632106 HLA-DQB1 Asthma
rs3807989 7 116183034 CAV1 PR interval
rs12680655 8 135604552 ZFAT Height
rs4929923 11 8642408 TRIM66 Menarche (age at onset)
rs12785878 11 71161461 RP11-660L16.2 Vitamin D insufficiency
rs12580100 12 56436876 RPS26 Psoriasis
rs4924410 15 40329664 SRP14 Ewing sarcoma
rs7364180 22 42184613 MEI1 Alzheimer’s disease biomarkers
doi:10.1371/journal.pgen.1003594.t007
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Reverse Transcriptase (Bioline) with 40 ng of random hexamer
and oligo(dT)18 primers following manufacturer’s instructions (for
the list of primer sequences see Table S7). Primers specific to short
or long variants of HPS1 were designed using Primer3Plus
program, primers for IRF5 were designed as previously described
[40]. qRT-PCR was performed on the LightCycler 480 (Roche)
using 26 SensiMix reagent (Bioline). 45 cycles of two-step PCR
were performed for HPS1, and 55 cycles of three-step PCR (95uC
for 15 s, 48uC for 15 s, and 60uC for 40 s) for IRF5. Each
measurement was performed in duplicates. PCR efficiency was
determined using the LinRegPCR program [41] v.11.1 according
to the described method [42]. Ratios between distal and proximal
PCR products were then calculated and significance was tested
performing a T-test.
Identifying causal SNPs affecting polyadenylation
We obtained all the proxy SNPs for all SNPs identified as cis-
regulating the choice of polyadenylation site. To do this we used
bi-allelic SNPs that pass QC from the 1000G European panel
(v3.20101123) and took all SNPs that were in linkage disequilib-
rium with the query SNPs (R2$0.8, distance between SNPs within
250 kb).
From this list of cis-regulating SNPs in linkage disequilibrium,
we kept only SNPs, which were located in the cis-regulated
genes. The filtering was performed by intersecting .bed files
containing SNPs coordinates and coordinates of cis-regulated
genes from RefSeq database, using table browser tool in UCSC
genome browser and the overlap intervals tool in Galaxy
(version 1.0.0).
Intersection of SNPs with validated and predicted polyadenyl-
ation sites was performed using annotation in the PolyA-DB
database (PolyA_DB 1 and PolyA_SVM) on UCSC (table browser
tool). Detection of SNPs within polyadenylation signals was
performed by extracting the strand specific sequence five
nucleotide upstream and downstream each SNP (using table
browser tool in UCSC) and performing a motif search using
custom Perl script. Canonical and non-canonical polyA motifs
searched were AATAAA, ATTAAA, TATAAA, AGTAAA,
AAGAAA, AATATA, AATACA, CATAAA, GATAA, AAT-
GAA, TTTAAA, ACTAAA, and AATAGA. For every SNP
located in a putative polyadenylation signal motif, the distance to
validated and predicted polyadenylation sites from PolyA-DB was
calculated. Only motifs within a distance of 30 nucleotides from a
polyadenylation site were considered true polyadenylation signals.
Newly formed polyadenylation signals were detected by changing
the reference allele of the SNP with the alternative allele, followed
by the same polyadenylation signal motif search using custom Perl
scripts.
For the cis-regulated genes where the SNP is located within a
true polyadenylation signal, we retrieved the coverage of every
SAGE tag upstream and downstream the putative affected
polyadenylation site and calculated the ratio between proximal
and distal tags for the different genotypes to confirm the expected
effects of polyadenylation site formation or disruption.
RNA-seq datasets
For the meta-analysis we combined DeepSAGE data with two
published RNA-seq datasets. The first dataset was 37 bp paired-
end RNA-sequencing data from HapMap individuals ([8],
[ArrayExpress:E-MTAB-197]): RNA from lymphoblastoid cell
lines of 60 HapMap CEPH individuals was sequenced on the
Illumina GAII sequencer, while genotype data had already been
generated within the HapMap project.
The second dataset was single-end RNA-sequencing data from
HapMap individuals [9,43] [GEO:GSE19480 and at http://eqtl.
uchicago.edu/RNA_Seq_data/]: RNA was sequenced from
lymphoblastoid cell lines of 72 HapMap Yoruba individuals from
Nigeria on the Illumina GAII platform in two sequencing centers:
Yale (using 35 bp reads) and Argonne (using 46 bp reads).
Since the Montgomery et al. paper used genotype data for some
individuals that were not in the HapMap3 panel (NA0851,
NA12004, NA12414 and NA12717), we imputed these individuals
using Beagle v3.1.0, with HapMap2 release 24 as a reference.
RNA-seq read mapping
Reads from single- and paired-end RNA-sequencing were
mapped to the human genome NCBI build 37 (reference
annotation from Ensembl GRCh37.65) using Tophat v. 1.3.3
[30] – a splice-aware aligner that maps RNA-seq reads to the
reference genome using Bowtie [21]. We used default settings
(maximum 2 mismatches, 20 possible alignments per read) with a
segment length value of 17 bp. Reads that corresponded to the
flag 1796 in the .bam alignment file (read unmapped, not primary
alignment, read fail quality check, read is PCR or optical
duplicate) were filtered out. The numbers of raw and mapped
reads for each dataset are given in Table 5.
Read quantification
To estimate expression levels in RNA-seq data, reads that
overlapped with exons from known transcripts (GRCh37.65) were
quantified using the coverageBed method from BEDTools suite
[39].
For transcript level quantification the read count Ctrs for sample
s for transcript tr was calculated as a sum of expression values over







fEtrg – set of all exons of transcript tr,
ne– number of reads overlapping exon e by not less than half of
read’s length,
Be– breadth of coverage for exon e (% of exon length covered by
the reads mapping to that exon).
In case a read mapped to multiple transcripts, the read was
counted for all transcripts, since the short reads are difficult to
assign to a specific transcript. Multiplication by breadth of
coverage was performed to help in distinguishing between different
isoforms by assigning higher weight to exons fully covered by reads
in contrast to alternative exons covered only partly.
Because different methods have different capacity to identify
alternative splicing events, we subsequently summarized our
eQTL results to unique genes.
Meta-analysis
Meta-analysis was conducted by using a weighted Z-method,
weighing each of the datasets by the square root of the number of
samples per dataset [6].
Microarray datasets
We compared the results to corresponding microarray dataset
eQTL mapping results. For each of the 94 individuals from NTR-
NESDA study, Affymetrix HG-U219 expression data were
generated at the Rutgers University Cell and DNA Repository
(RUCDR, http://www.rucdr.org). NTR and NESDA samples
DeepSAGE eQTL Mapping
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were randomly assigned to plates with seven plates containing
subjects from both studies to better inform array QC and study
comparability. Gene expression data were required to pass
standard Affymetrix QC metrics (Affymetrix expression console)
before further analysis. Probe sets were removed when their
mapping location was ambiguous or if their location intersected a
polymorphic SNP (dropped if the probe oligonucleotide sequence
did not map uniquely to hg19 or if the probe contained a
polymorphic SNP based on HapMap3 [44] and 1000 Genomes
[45] project data). Expression values were obtained using RMA
normalization implemented in Affymetrix Power Tools (APT, v
1.12.0). MixupMapper revealed no sample mix-ups [46].
For RNA-seq data we used corresponding microarray datasets
that were available for most of the individuals present in RNA-seq
datasets. We used Illumina expression data provided by Stranger et
al. [3] of the 72 HapMap YRI individuals (56 of which were also
present in RNA-seq dataset from Pickrell et al.) and 60 HapMap
CEU individuals provided by Montgomery et al. (58 of which were
also present in RNA-seq dataset from Montgomery et al.).
The same normalization procedure was performed as for the
sequencing-based datasets: quantile normalization, and subse-
quent probe set centering to zero, z-score transformation, and
scaling to a standard deviation of one.
Data access
The newly generated DeepSAGE data for NTR-NESDA
dataset is available in ArrayExpress under accession number E-
MTAB-1181 (ENA: ERP001544).
Supporting Information
Figure S1 Correlation of GC content with principal component
1 (PC1) eigenvector coefficients for all the three datasets. Pearson
correlation coefficient and corresponding p-value are shown in the
plot.
(EPS)
Figure S2 Blood cell counts in DeepSAGE data captured by the
eigenvector coefficients on principal components PC7 (left) and
PC11 (right). Experimentally determined blood cell counts at the
time of RNA isolation were available for 36/94 samples. Blood cell
counts are expressed as (number of cells)6109/L. Pearson
correlation coefficients and corresponding p-values are shown in
the plot.
(EPS)
Figure S3 Replication of Affymetrix eQTLs in DeepSAGE
dataset and DeepSAGE eQTLs in Affymetrix data. The numbers
of unique cis-regulated genes is given after each filtering step.
(EPS)
Table S1 List of detected eQTLs in tag-wise eQTL mapping.
(XLS)
Table S2 Trait-associated SNPs affecting the expression of
DeepSAGE tags of 94 peripheral blood samples.
(XLS)
Table S3 List of candidate genes with alternative polyadenyla-
tion event detected using a permissive strategy.
(XLS)
Table S4 Replications between RNA-seq and DeepSAGE
eQTLs.
(XLS)
Table S5 Replication of RNA-seq eQTLs in microarray-based
datasets.
(XLS)
Table S6 List of detected eQTLs in the meta-analysis.
(XLS)
Table S7 Primer sequences for qPCR validation.
(XLS)
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